EMILY BERGERON: Open Payments
NPI 1033627906 · FRANKLIN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 31 payments from 15 companies in 2025. Trend: 2023 $44 · 2024 $65 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $194 |
| Alkermes, Inc. | 10 | $144 |
| Exact Sciences Corporation | 2 | $137 |
| UCB, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Amgen Inc. | 1 | $71 |
| Novartis Pharmaceuticals Corporation | 1 | $67 |
| Shockwave Medical, Inc | 1 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
Products named: ARISTADA, The Cologuard Plus Collection Kit, UZEDY, Bimzelx, Auvelity, OTEZLA, COSENTYX, REXULTI.
Industry payments across LA — which companies pay providers there.
